Crinetics Pharmaceuticals CRNX D&A

D&A at other companies

Neurocrine BiosciencesNBIX

$7.2M+9.1%

Corcept TherapeuticsCORT

$863K+202%

BridgeBio PharmaBBIO

$1.19M-7.6%

MBX Biosciences, Inc.MBX

$64K-16.9%

XER

Xeris Biopharma Holdings, Inc.XERS

$323K-0.6%

Amylyx Pharmaceuticals, Inc.AMLX

$43K-69.5%

FAQ

What is Crinetics Pharmaceuticals's D&A?

Crinetics Pharmaceuticals (CRNX) reported D&A of $1.16M in Q1 2026.

How has Crinetics Pharmaceuticals's D&A changed year-over-year?

Crinetics Pharmaceuticals's D&A increased by 25.4% year-over-year, from $925K to $1.16M.

What is the long-term trend for Crinetics Pharmaceuticals's D&A?

Over 4 years (2021 to 2025), Crinetics Pharmaceuticals's D&A has grown at a 43.3% compound annual growth rate (CAGR), from $922K to $3.89M.

What does D&A mean?

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.